Renoprotective effects of C-peptide in the Dahl salt-sensitive rat

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 6, 2012, Pages

  Taylor Sawyer, R ^a   Flynn, Elizabeth R ^a   Hutchens, Zachary M ^a   Williams, Jan M ^a,b   Garrett, Michael R ^a,b   Maric Bilkan, Christine ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Albuminuria; Glomerular permeability; Kidney; Proteinuria

Indexed keywords

ALBUMIN; C PEPTIDE; PODOCIN; TRANSFORMING GROWTH FACTOR BETA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; GLOMERULOSCLEROSIS; INFLAMMATION; KIDNEY INJURY; MALE; NEPHRITIS; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION;

EID: 84866386292     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00068.2012     Document Type: Article

References (31)

1. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17: 2974-2984, 2006.
2. Chima RS, Maltese G, Lamontagne T, Piraino G, Denenberg A, O'Connor M, Zingarelli B. C-peptide ameliorates kidney injury following hemorrhagic shock. Shock 35: 524-529, 2011.
3. Faber OK, Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes 26: 605-610, 1977.
4. 1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy. Am J Physiol Renal Physiol 296: F614-F621, 2009.
5. Hills CE, Brunskill NJ, Squires PE. C-peptide as a therapeutic tool in diabetic nephropathy. Am J Nephrol 31: 389-397, 2010.
6. Hills CE, Willars GB, Brunskill NJ. Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 24: 822-831, 2010.
7. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA. Podocytespecific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19: 2069-2075, 2008.
8. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278-1283, 1975.
9. Huang DY, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn Schmiedebergs Arch Pharmacol 365: 67-73, 2002.
10. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 17: 181-189, 2000.
11. Li L, Oshida Y, Kusunoki M, Yamanouchi K, Johansson BL, Wahren J, Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 42: 958-964, 1999.
12. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011.
13. Mankhey R, Wells CC, Bhatti F, Maric C. 17β-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 292: R769-R777, 2007.
14. Maric C, Flynn ER, Chade RA. Treatment with C-peptide slows the progression of diabetic renal disease in the streptozotocin (STZ)-induced diabetic rat. In: Experimental Biology. Anaheim, CA: FASEB J, 2011, p. 664.662.
15. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol 170: 36-47, 2011.
16. Nordquist L, Brown R, Fasching A, Persson P, Palm F. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Renal Physiol 297: F1265-F1272, 2009.
17. Nordquist L, Lai EY, Sjoquist M, Patzak A, Persson AE. Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. Am J Physiol Regul Integr Comp Physiol 294: R836-R841, 2008.
18. Rebsomen L, Pitel S, Boubred F, Buffat C, Feuerstein JM, Raccah D, Vague P, Tsimaratos M. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab 32: 223-228, 2006.
19. Rodriguez-Iturbe B, Garcia Garcia G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 116: c81-88, 2010.
20. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjoquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20: 532-538, 2005.
21. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60: 1258-1265, 2001.
22. Sato Y, Oshida Y, Han YQ, Morishita Y, Li L, Ekberg K, Jornvall H, Wahren J. C-peptide fragments stimulate glucose utilization in diabetic rats. Cell Mol Life Sci 61: 727-732, 2004.
23. Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3: 1260-1269, 1992.
24. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54: 758-764, 1998.
25. Steiner DF. The proinsulin C-peptide-a multirole model. Exp Diabesity Res 5: 7-14, 2004.
26. Stridh S, Sallstrom J, Friden M, Hansell P, Nordquist L, Palm F. C-peptide normalizes glomerular filtration rate in hyperfiltrating conscious diabetic rats. Adv Exp Med Biol 645: 219-225, 2009.
27. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19: 495-502, 2008.
28. Tryggvason K, Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10: 543-549, 2001.
29. Xu Q, Prabhu A, Xu S, Manigrasso MB, Maric C. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney. Am J Physiol Renal Physiol 297: F307-F315, 2009.
30. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R, Racusen LC, Reckelhoff JF. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med 8: 103-115, 2011.
31. Zhu Y, Usui HK, Sharma K. Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol 27: 153-160, 2007.